Tocilizumab in COVID-19 Lahore General Hospital

Clinical trial NCT04560205 · UNKNOWN

Trial details

NCT number: NCT04560205
Sponsor: Lahore General Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

SARS-CoV Infection

Start date: 2020-05-01
Primary completion: 2020-12-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.